Lv6
3190 积分 2022-11-05 加入
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial
1个月前
已完结
Targeting ATR in patients with cancer
1个月前
已完结
The activation mechanisms of master kinases in the DNA damage response
1个月前
已完结
The essential kinase ATR: ensuring faithful duplication of a challenging genome
1个月前
已完结
An Overview of PARP Inhibitors for the Treatment of Breast Cancer
2个月前
已完结
DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications
2个月前
已完结
Targeting DNA damage response pathways in cancer
2个月前
已完结
皖公网安备34019202002308
